Karen K Mcpherson, APRN | |
309 S Edline, Jefferson Comprehensive Care, Altheimer, AR 72004-8559 | |
(870) 766-8411 | |
(870) 766-8412 |
Full Name | Karen K Mcpherson |
---|---|
Gender | Female |
Speciality | Nurse Practitioner - Family |
Location | 309 S Edline, Altheimer, Arkansas |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1114945052 | NPI | - | NPPES |
154472001 | Medicaid | AR |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
363LF0000X | Nurse Practitioner - Family | A01695 (Arkansas) | Primary |
Mailing Address | Practice Location Address |
---|---|
Karen K Mcpherson, APRN 309 S Edline, Jefferson Comprehensive Care, Altheimer, AR 72004-8559 Ph: (870) 766-8411 | Karen K Mcpherson, APRN 309 S Edline, Jefferson Comprehensive Care, Altheimer, AR 72004-8559 Ph: (870) 766-8411 |
News Archive
Stemedica Cell Technologies, Inc., a world leader in stem cell research and manufacturing, announced that the U.S. Food and Drug Administration (FDA) approved an Investigational New Drug (IND) for a clinical trial for ischemic stroke using Stemedica's high potency proprietary allogeneic stem cells (adult human).
UL (Underwriters Laboratories), a global safety science company, announced today it is entering into a relationship with world-renown toxicologists and researchers to develop a cutting-edge tool to predict the toxicity of chemicals.
Despite progress in raising the vaccination rates in the world's poorest countries, some countries, including the Democratic Republic of Congo, Ethiopia, India, Indonesia and Nigeria continue to have vaccination rates "below 50% in certain regions, compared with the 80% or more needed to achieve a low risk of the disease spreading," Douglas Holt, Oxford University professor of marketing, and Jacob McKnight, also of Oxford University, write in a Livemint.com analysis piece.
Researchers from the University of Malaya in Malaysia, with collaboration from researchers from the University of Portsmouth and the University of Oxford in the United Kingdom, announce the creation of a cost-effective two-part model of the skull for use in practicing neurosurgical techniques. The model, produced using the latest generation of multimaterial 3D printers, is composed of a variety of materials that simulate the various consistencies and densities of human tissues encountered during neurosurgery.
Happily, a path back to the future exists that just might be politically actionable in a divided Washington. It involves not repealing ObamaCare but adding something to it an optional federal charter for health insurers.
› Verified 6 days ago